Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Sentiment Is Stagnant On CEVA, Inc. (CEVA)

The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentives to do the research necessary to beat the market. That’s why we pay close attention to what they think in small cap stocks. In this article, we take a closer look at CEVA, Inc. (NASDAQ:CEVA) from the perspective of those elite funds.

CEVA, Inc. (NASDAQ:CEVA) shares haven’t seen a lot of action during the second quarter. Overall, hedge fund sentiment was unchanged. The stock was in 10 hedge funds’ portfolios at the end of June. At the end of this article we will also compare CEVA to other stocks including Diamond S Shipping Inc. (NYSE:DSSI), Fossil Group Inc (NASDAQ:FOSL), and Magenta Therapeutics, Inc. (NASDAQ:MGTA) to get a better sense of its popularity. Our calculations also showed that CEVA isn’t among the 30 most popular stocks among hedge funds (see the video below).
5 Most Popular Stocks Among Hedge Funds
Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

Today there are many methods stock traders put to use to analyze stocks. A couple of the best methods are hedge fund and insider trading interest. We have shown that, historically, those who follow the best picks of the best money managers can outclass the S&P 500 by a solid margin (see the details here).

John Overdeck of Two Sigma

Unlike former hedge manager, Dr. Steve Sjuggerud, who is convinced Dow will soar past 40000, our long-short investment strategy doesn’t rely on bull markets to deliver double digit returns. We only rely on hedge fund buy/sell signals. Let’s take a gander at the new hedge fund action surrounding CEVA, Inc. (NASDAQ:CEVA).

How are hedge funds trading CEVA, Inc. (NASDAQ:CEVA)?

At the end of the second quarter, a total of 10 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 0% from the first quarter of 2019. Below, you can check out the change in hedge fund sentiment towards CEVA over the last 16 quarters. With hedgies’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).

No of Hedge Funds with CEVA Positions

Among these funds, Millennium Management held the most valuable stake in CEVA, Inc. (NASDAQ:CEVA), which was worth $6.9 million at the end of the second quarter. On the second spot was Renaissance Technologies which amassed $6 million worth of shares. Moreover, D E Shaw, Two Sigma Advisors, and Citadel Investment Group were also bullish on CEVA, Inc. (NASDAQ:CEVA), allocating a large percentage of their portfolios to this stock.

Due to the fact that CEVA, Inc. (NASDAQ:CEVA) has faced a decline in interest from the smart money, we can see that there exists a select few funds who were dropping their full holdings last quarter. Interestingly, Andrew Feldstein and Stephen Siderow’s Blue Mountain Capital dropped the biggest investment of the 750 funds followed by Insider Monkey, worth an estimated $0.3 million in stock. Bruce Kovner’s fund, Caxton Associates LP, also said goodbye to its stock, about $0.2 million worth. These bearish behaviors are important to note, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s check out hedge fund activity in other stocks similar to CEVA, Inc. (NASDAQ:CEVA). We will take a look at Diamond S Shipping Inc. (NYSE:DSSI), Fossil Group Inc (NASDAQ:FOSL), Magenta Therapeutics, Inc. (NASDAQ:MGTA), and Akebia Therapeutics Inc (NASDAQ:AKBA). This group of stocks’ market caps resemble CEVA’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
DSSI 11 149769 4
FOSL 13 66559 -4
MGTA 8 72421 0
AKBA 14 194634 -5
Average 11.5 120846 -1.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 11.5 hedge funds with bullish positions and the average amount invested in these stocks was $121 million. That figure was $26 million in CEVA’s case. Akebia Therapeutics Inc (NASDAQ:AKBA) is the most popular stock in this table. On the other hand Magenta Therapeutics, Inc. (NASDAQ:MGTA) is the least popular one with only 8 bullish hedge fund positions. CEVA, Inc. (NASDAQ:CEVA) is not the least popular stock in this group but hedge fund interest is still below average. Our calculations showed that top 20 most popular stocks among hedge funds returned 24.4% in 2019 through September 30th and outperformed the S&P 500 ETF (SPY) by 4 percentage points. A small number of hedge funds were also right about betting on CEVA as the stock returned 22.6% during the same time frame and outperformed the market by an even larger margin.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.